| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1440-1746.2004.03451.X |
| P698 | PubMed publication ID | 15482536 |
| P50 | author | Katie Allen | Q38589865 |
| P F Wright | Q67808153 | ||
| P2093 | author name string | Sophie Gazeas | |
| Robert Williamson | |||
| Nicole E Pettigrew-Buck | |||
| Daphne My Cheah | |||
| Julian Fb Mercer | |||
| Yolanda H Deal | |||
| P2860 | cites work | Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation | Q28270302 |
| Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase | Q31830057 | ||
| Liver cell transplantation: the road to clinical application. | Q34440059 | ||
| Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine | Q35753154 | ||
| Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. | Q39394474 | ||
| Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease | Q43556283 | ||
| Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. | Q45876212 | ||
| The toxic milk mouse is a murine model of Wilson disease | Q48059534 | ||
| Defective localization of the Wilson disease protein (ATP7B) in the mammary gland of the toxic milk mouse and the effects of copper supplementation | Q59154486 | ||
| P433 | issue | 11 | |
| P921 | main subject | gastroenterology | Q120569 |
| P304 | page(s) | 1283-1290 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
| P1476 | title | Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease | |
| P478 | volume | 19 |
| Q36084471 | AAV-mediated gene targeting is significantly enhanced by transient inhibition of nonhomologous end joining or the proteasome in vivo |
| Q35105022 | Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo. |
| Q33752265 | Cell therapy to remove excess copper in Wilson's disease |
| Q37221342 | Cell-based therapies for metabolic liver disease |
| Q51650805 | Copper comes of age in Melbourne. |
| Q37278160 | Correction of copper metabolism is not sustained long term in Wilson's disease mice post bone marrow transplantation. |
| Q36980068 | Embryonic and induced pluripotent stem cells as a model for liver disease |
| Q42571919 | Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). |
| Q38025743 | Hepatocyte transplantation for inherited metabolic diseases of the liver. |
| Q53186451 | Hepatogenic differentiation from human adipose-derived stem cells and application for mouse acute liver injury. |
| Q35776326 | In Situ Transplantation of Alginate Bioencapsulated Adipose Tissues Derived Stem Cells (ADSCs) via Hepatic Injection in a Mouse Model |
| Q36298651 | In vivo selection of transplanted hepatocytes by pharmacological inhibition of fumarylacetoacetate hydrolase in wild-type mice |
| Q42226193 | Longitudinal analysis of serum miR-122 in a rat model of Wilson's disease. |
| Q39896527 | Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver |
| Q35990789 | New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases |
| Q36368243 | Stem cells for the treatment of liver disease |
| Q42974100 | Transplantation of immortalized human fetal hepatocytes prevents acute liver failure in 90% hepatectomized mice |
Search more.